Peripheral arterial disease in randomized trial of estrogen with progestin in women with coronary heart disease: The heart and estrogen/progestin replacement study.
(Effects of oral and transdermal hormone replacement therapies with and without C21-gestagens on serum lipids and lipoproteins in postmenopausal women.)
Risks of coronary heart disease in women: Current understanding and evolving concepts.
A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease.
Impact of estrogen alone and combined with medroxyprogesterone acetate on vascular reactivity in postmenopausal women.
Postmenopausal hormone replacement therapy and the vascular wall: Epidemiology and clinical studies.
Coronary heart disease in women.
Coronary heart disease in women: The authors reply.
Estrogen receptor-mediated inhibition of inflammatory gene expression in human endothelial cells.
The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in post-menopausal women.
Dyslipidemia, gender, and the role of high-density lipoprotein cholesterol: Implications for therapy.
Hyperlipidaemia and cardiovascular disease.
Conjugated equine estrogen improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetes.
Editorial: Soy phytoestrogens, lipid reductions, and atherosclerosis delay in ovariectomized primates.
Estrogens, lipids and cardiovascular disease: No easy answers.
Estrogen-induced small low density lipoprotein particles may be atherogenic in postmenopausal women.
Lipolytic enzyme effect on small low-density lipoprotein particles in women treated with estrogen.
Separate and combined effects of hormone replacement and simvastatin 10 mg on lipoprotein (a) and lipoprotein subfractions in postmenopausal women with hypercholesterolemia.
Effect of lipid lowering therapy with atorvastatin alone or in association with different hormone replacement schemes in female patients with severe hypercholesterolemia.
Cardiovascular disease and dyslipidemia in women.
Postmenopausal hormone therapy and coronary heart disease.
Risk factors for coronary artery disease and women: Modification and evidence of benefit.
(Secondary and tertiary prevention of atherosclerotic vessel diseases.)
